5.2 CV system & diabetes Flashcards

1
Q
  • prevalence of diabetes in Canada: increase with (2)
A
  • increases with age and with increasing richness ish (rich ppl disease)
    *but actually increasing in all ages now
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

what happens/is when blood glucose is
- 5mM (90 mg/dL)
- 6.1 mM (110 mg/dL)
- 7.8mM (140 mg/dL)
- 11.1mM (200 mg/dL)
- 16.6mM (300 mg/dL)
- 22.2mM (400 mg/dL)
- 33.3mM (600 mg/dL)

A
  • 5mM (90 mg/dL): nothing
  • 6.1 mM (110 mg/dL): normal
  • 7.8mM (140 mg/dL): prediabetes
  • 11.1mM (200 mg/dL): diabetes
  • 16.6mM (300 mg/dL): b cell destruction begins
  • 22.2mM (400 mg/dL): b cell destruction + ketoacidosis –> T2D becomes insulin dependant
  • 33.3mM (600 mg/dL): diabetic coma
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

what happens/is when glycated hemoglobin (HbA1C) is:
- <5.7%:
- 5.7-6.4%:
- > 6.4%:

A
  • <5.7%: normal
  • 5.7-6.4%: prediabetes
  • > 6.4%: diabetes
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

give blood glucose values for:
- normal
- prediabetes
- diabetes
- b-cell destruction begins
- b-cell destruction + ketoacidosis
- diabetic coma

A
  • 5mM (90 mg/dL): nothing
  • 6.1 mM (110 mg/dL): normal
  • 7.8mM (140 mg/dL): prediabetes
  • 11.1mM (200 mg/dL): diabetes
  • 16.6mM (300 mg/dL): b cell destruction begins
  • 22.2mM (400 mg/dL): b cell destruction + ketoacidosis –> T2D becomes insulin dependant
  • 33.3mM (600 mg/dL): diabetic coma
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

what does it mean to be prediabetic?

A
  • blood glucose and glycated hemoglobin are a bit high –> still normal glucose metabolism but higher risk of diabetes
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

what are the 2 forms of diabetes mellitus?
- cause?
- usually develops when?

A

Type 1:
- insufficient production of insulin –> usually due to autoimmune destruction of b-cells
- usually develops early in life (but possible in older adults as well
- used to be called insulin-dependant or juvenile diabetes, but not anymore
TYPE 2:
- insulin resistance! –> cells don’t respond appropriately to insulin
- usually develops in late adulthood –> associated with obesity (but not all obese are diabetic)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

insulin resistance:
- is it metabolic actions or endocrine actions that are altered? give examples

A

METABOLIC!!
- how glucose metabolism is regulated
- glucose uptake in muscle/adipocytes, glycolysis, glycogenolysis, lipolysis, gluconeogenesis
VS ENDOCRINE:
- growth factor: cell proliferation and differentiation
*prolonged diabetes can lead to abnormal endocrine functions as well

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

etiology of Type 1 diabetes:
- ___-____% of cases
- autoantibodies against (3)
- OR _____________

A
  • 5-10% of cases
    1. INSULIN: b cells function normally but antibodies for insulin in body = insulin function doesn’t take place –> glucose metabolism is disrupted –> can lead to overproduction of insulin/overactivation of b-cells –> eventually get destroyed bc of increased function
    2. GLUTAMATE DECARBOXYLASE (GAD):
  • converts glutamate to GABA (neurotransmitter)
  • GAD promotes insulin release in b-cells (not synthesis)
  • multiple types of GAD antibodies = issue in insulin release = more insulin is produced…
    3. ISLET ANTIGEN-2
  • isoform of tyrosine phosphatase-like protein in b-cells –> function unknown but antibodies against it leads to abnormal release of insulin, leading to T1D
    OR idiopathic! (causes remain unknown)
    *antibodies of GAD and islet antigen-2 were discovered in clinical samples of people who have T1D
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

etiology of diabetes type 2:
- __-__% of cases
- main (general) cause: insulin ________ or insulin _______ ________
- 3 possible causes

A
  • 80-95% of cases
  • insulin resistance or insulin secretory defect (or insulin resistance leading to insulin secretory defect)
    1. genetic defects of b-cell function: mutations
    2. disease of exocrine pancreas
    3. endocrinopathies: abnormal functioning of another hormonal system
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

describe the genetic defects of b-cell functions (mutations) that can cause T2D (1 with lots of info + 3)

A
  1. glucokinase (GCK) (hexokinase 4)
    - present in liver and pancreas (b-cells)
    - hexokinase IV = smallest of the hexokinases
    - sense glucose in b-cells
    - mutation = 30x more sensitive –> can lead to increase insulin or insulin release defects –> leads to abnormal glucose homeostasis/insulin resistance = T2D
  2. HNF (a transcription factor)
  3. PDX1 (transcription factor)
  4. mitochondrial DNA 3242
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

which diseases of the exocrine pancreas can lead to T2D? (4)

A
  • pancreatitis
  • trauma
  • surgery (pancreatectomy)
  • tumor
    *all would lead to abnormal b-cell function = T2D
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

which endocrinopathies can lead to T2D? (6)

A
  1. CUSHING’S SYNDROME
    - high cortisol –> inhibits insulin and promotes gluconeogenesis
    - cortisol = opposite of insulin action –> glu stays in blood = tells b-cells to make more insulin –> b-cells work too hard
  2. ACROMEGALY:
    - high GH –> opposite of insulin actioss of glucose uptake and lipogenesis –> same as cortisol
  3. PHEOCROMOCYTOMA
    - tumor of adrenal medulla –> high catecholamine –> need more glu in circulation –> leads to overfunction of b-cells = IR = T2D
  4. GLUCAGONOMA
    - tumors of a-cells –> produce glucagon
    - too much glucagon = increase insulin = IR or destruction of b-cells
  5. HYPERTHYROIDISM
    - T3/T4 stimulate lipolysis, muscle catabolism and carbohydrate absorption VS insulin promotes reduction of all 3
    - increase T3/T4 leads to overprod of insulin = IR and T2D
  6. SOMATOSTATINOMA
    - somatostatin produced in multiple locations –> inhibits insulin secretion in islets of lagerhans + hypothalamus + GI –> leads to defective insulin function
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

why does an increase in a hormone opposite of insulin can lead to T2D?

A
  • bc hormone will make more glucose stay in bloodstream –> GCK senses it –> produces more insulin to decrease blood glucose –> overprod of insulin –> leads to overfunction of b-cells OR insulin resistance (abnormal response to insulin from muscle, adipose and liver)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

explainpre-receptor (2) vs receptor (4) insulin resistance
- which one is more common?

A

PRE-RECEPTOR:
- antibodies against insulin
- mutant insulin: A-C and B-C insulin (vs A-B)
*both lead to abnormal signaling
RECEPTOR: (after ligand binds)
- reduced INSR expression
- reduced affinity for insulin: need more insulin to elicit same response
- impaired tyrosine-kinase activity (intrinsic) –> leads to abnormal signaling
- INSR antibodies
*or any abnormality in any stage of INSR signaling (ie negative feedback regulators…) –> leads to IR

  • receptor is more common! pre-receptor is less common
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

insulin action: normal vs diabetes SCHÉMA!
- insulin from pancreas acts on (3) –> what happens?

A

NORMAL glucose homeostasis
- insulin reaches brain –> decrease sympathetic outflow to adipose tissue = decrease lipolysis
- insulin reaches brain –> unknown neuronal signal to liver to increase TG secretion
- insulin reaches fat to decrease lipolysis –> signals to fat to decrease TG synthesis
- insulin reaches liver to decrease gluconeogenesis and decrease TG secretion
DIABETES: = decrease insulin!
- less insulin reaches brain –> INCREASE sympathetic outflow to adipose tissue = INCREASE lipolysis
- less insulin reaches brain –> unknown neuronal signal to liver to DECREASE TG secretion + more glucose from liver to brain!
- less insulin reaches fat –> INCREASE lipolysis –> INCREASE NEFA signals liver to increase TG synthesis
- LESS insulin reaches liver: INCREASE gluconeogenesis and decrease TG secretion
*overall increase in TG synthesis and decrease TG secretion = fatty liver –> abnormal energy met (glu and fat)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

DIABETES SYMPTOMS:
- in both forms of diabetes, what is elevated?
- body tries to dilute _____, leading to excessive (2)
- in T1D: what is accelerated (why?), leading to high production of what?
- untreated diabetes leads to what?

A
  • blood sugar is elevated
  • dilute the glucose, leading to excessive thirst (increase water = abnormal fluid met) and urination –> polydipsia and polyuria
  • fat breakdown/lipolysis is accelerated (bc low insulin, no sugar is taken up, cells don’t have E) –> leads to high production of ketone bodies
  • leads to dramatic weight loss (bc increase lipolysis and increase proteolysis)
17
Q
  • which ketoacid raises blood pH? –> leads to __________
  • what system is disrupted? leading to what?
    formula!
  • which other ketone body is expelled via breath?
A
  • acetoacetic acid –> raises blood [H+], leading to ketoacidosis (increase acidity of blood)
  • bicarbonate buffering system is disrupted, leading to altered breathing
  • CO2 + H2O <–> H2CO2 <–> HCO3- + H+
    *H2CO2 = carbonic acid
    *HCO3- = bicarbonate
  • increase H+ push rxn to the left = increase CO2 = increase shallow breathing
  • acetone! really small molecule –> giving characteristic acetone/sweet breath
18
Q

long-term effects of elevated blood sugar
- proteins can be _________, especially where?
- excessive glucose causes what?
- ___________ can also be _________ –> 2 consequences
- increased blood sugar increases risk of (4)

A
  • proteins can be glycated, especially at free amino group –> physiological enzyme-regulated process
  • excessive glucose causes glycation –> non-enzymatic reaction = abnormal = function of enzyme is altered
  • Hemoglobin can also be glycated as entry of glucose into erythrocytes is not regulated (diffusion through GLUT1) *RBC can only use glucose bc no nuclei or mitochondria
    1. compromises O2 delivery (inefficient carrying), especially at extremities (feet)
    2. results in impaired injury repair!
  • increase risk of CV disease, renal failure, damage to small blood vessel and damage to nerves = multisystem failure
19
Q
  • in 2017, ___% of canadians aged 12 and older (around 2.3M ppl) reported being diagnosed with diabetes –> ___% had T2D
  • metabolic syndrome: cluster of symptoms/comorbidities (5) with insulin resistance
A
  • 7.3% –> 90% are T2D
    1. abdominal obesity
    2. high triglycerides (TAGs)
    3. low HDL
    4. high blood pressure
    5. elevated blood glucose (but may not be full-blown diabetic)
20
Q

what is the lipid burden hypothesis?
- path from what to what?
- explain process (4 steps)

A
  • path from obesity to type 2 diabetes
    *80% of T2 diabetics are obese, but the minority of obese individuals develop diabetes
    1. increased adipocytes become packed and unable to accommodate more TG
    2. inability to deposit TG leads to spillage of NEFA in blood (NEFA from extra TG and increased lipolysis)
    3. excess NEFA enter muscle and liver –> create TAG lipid droplets and cause these organs to lose sensitivity to insulin (ie insulin brings GLUT4 to muscle cell membranes –> inhibited if abnormal lipid accumulation in muscles)
    4. ultimately, blood glucose levels rise
21
Q

general mechanism of lipid burden hypothesis ish –> overloading adipocytes schéma
1. lean/normal glu and FA
2. overweight
3. pro-inflammatory state
4. chronic inflammation
*which ones have insulin-sensitive muscle with normal glucose transport? vs insulin-resistant muscle with reduced glu transport

A
  1. lean/normal glu and FA
    - small adipocytes
    - both FA and glucose can enter muscle to make ATP
  2. overweight:
    - larger adipocytes:
    - muscle can still maintain normal fct and use both FA and glu to make ATP
  3. pro-inflammatory state:
    - enlarged adipocytes produce monocyte chemotaxis protein (MCP-1)
    - FA (and glu) still managed by muscle –> muscle maintains insulin sensitivity
  4. chronic inflammation:
    a) macrophages infiltrate adipose tissue in response to MCP-1
    b) macrophages produce TNFa (pro-inflammatory cytokine), which favors export of FA
    c) adipocytes export FA to muscle, where ectopic lipid deposits form (in muscle)
    d) ectopic lipid interferes with GLUT4 movement to myocyte surface, producing insulin resistance = decrease glu uptake = more glu in circulation = diabetes
22
Q

TREATMENT OPTIONS FOR DIABETES:
1.first line of treatment?
- highly effective in which patients?
- reduces (3)
- what produces fuel for muscle, liver and myocardium?
2. 2 meds increase insulin sensitivity and decrease glucose output (gluconeogenesis) by liver
3. 2 other meds promote insulin secretion from pancreas
4. which med increase insulin secretion?
5. which med decrease absorption of CHO from intestine?

A
  1. weight loss!
    - highly effective in overweight patients with T2DM (even 5-10% loss improves glu homeostasis)
    - reduces insulin resistance, hepatic glucose production and fasting hyperinsulinemia
    - with reduced cal intake, adipose tissue-derived NEFA provide fuel for muscle, liver and myocardium
  2. Metformin and thiazolidinediones
  3. sulfonylureas and meglitinides
  4. GLP-1 receptor agonists (semaglutide/ozempic)
  5. alpha-glucosidase inhibitors
23
Q

what do these meds do?
1. GLP1 receptor agonists
2. metformin and thiazolidinediones
3. alpha-glucosidase inhibitors
4. sulfonylureas and meglitinides

A
  1. increase insulin secretion (semaglutide/Ozempic)
  2. increase insulin sensitivity and decrease glucose output (gluconeogenesis) by liver
  3. decrease absorption of CHO from intestine
  4. promote insulin secretion from pancreas